Taken together with our previous results, this suggests that inhibition of both MCL-1 and BCL-2 is required to reduce M.tb growth in granulomas, and that targeting both MCL-1 and BCL-2 is a potential promising option for HDT for TB. This evidence concerns the gene MCL1 and tuberculosis.